Deutsche Bank analyst issues MIXED recommendation for NVDA on October 12, 2026 08:20PM ET. The previous analyst recommendation was Buy.NVDA was trading at $226.32 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 2 - Strong Buy, 58 - Buy, 16 - Hold, 3 - Sell recommendations .Historical Analyst...
Akash Tewari from Jefferies issued a price target of $76.00 for BMY on 2026-10-12 19:48:23.The adjusted...
Following are the Top 5 companies based on their one-day percentage change within the 'Tech Stocks'...
Following are the Top 5 companies based on their one-day percentage change within the 'Software as...
Following are the Top 5 companies based on their one-day percentage change within the 'Founder Led...
Akash Tewari from Jefferies issued a price target of $76.00 for BMY on 2026-10-12 19:48:23.The adjusted price target was set to $76.00.At the time of the announcement, BMY was trading...
from Argus Research issued a price target of $95.00 for DAL on 2026-10-12 13:06:30.The adjusted price target was set to $95.00.At the time of the announcement, DAL was trading at...
Thomas Palmer from Coker Palmer issued a price target of $75.00 for ADM on 2026-10-12 12:41:50.The adjusted price target was set to $75.00.At the time of the announcement, ADM was...
from BMO Capital issued a price target of $105.00 for DAL on 2026-10-12 12:40:57.The adjusted price target was set to $105.00.At the time of the announcement, DAL was trading at...
Brad Zelnick from Deutsche Bank issued a price target of $600.00 for MSFT on 2026-10-12 12:38:24.The adjusted price target was set to $600.00.At the time of the announcement, MSFT was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In a bold move to strengthen its position in the rapidly evolving artificial intelligence sector, Microsoft has started rolling out its latest customized Maia chips in data centers, aiming to...
Micron Technology Inc. (NASDAQ: MU) is facing a challenging day in the stock market, as its shares have dropped 3.6% to $991.93. This decline is impacting the broader semiconductor sector,...
In recent news, Jack Nekhala, one of the founders of the popular Bed Scrunchie, reported a significant setback when Amazon deactivated his seller account, leading to substantial financial strain on...
On October 12, 2026, Glancy Prongay Wolke & Rotter LLP announced a significant opportunity for investors who have incurred losses to lead a securities fraud class action lawsuit against Alphabet...
Los Angeles-based Glancy Prongay Wolke & Rotter LLP announced on October 12, 2026, that investors suffering losses from Alphabet Inc. (NASDAQ: GOOGL) now have the chance to lead a class...
